Dr Michal Lubomski is a neurologist with a specialist interest in Movement Disorders, particularly in the use of device assisted therapies for Parkinson’s disease. He is completing his PhD at the Kolling Institute, University of Sydney investigating the gastrointestinal microbiome in Parkinson’s disease, supervised by Prof Carolyn Sue and Dr Ryan Davis. Michal’s research has attracted funding from Parkinson’s NSW, The Royal Australasian College of Physici ans and The University of Sydney. Michal is a Clinical Senior Lecturer, having completed his Medical Degree at the University of Notre Dame, Sydney. He is currently working at the Prince of Wales and Royal North Shore Hospitals, having previously undertak en his Neurology training at St Vincent’s, Concord and Royal Prince Alfred Hospitals and subsequently completing his Fellowship at Royal North Shore Hospital. His future interests aim to bridge neurodegenerative scientific research into clinical practice.
Stephen Winters is a full – time Staff Specialist in Vascular and Interventional Neurology at Royal Prince Alfred Hospital. He recently returned from a clinical and interventional neuroradiology fellowship in Tennessee where strokes rates are some of the hig hest in the world. Prior to this he was the fellow for interventional neuroradiology at Royal Prince Alfred Hospital. He is also the co – founder of Rounds and Trazepp Medical, an acute care platform for acute stroke and neurology care.
Professor Susan Kurrle
Susan Kurrle is a geriatrician at Hornsby Ku – ring – gai Hospital in northern Sydney and at Batemans Bay Ho spital in southern NSW. She holds the Curran Chair in Health Care of Older People in the Faculty of Medicine at the University of Sydney. She has had a long interest in the diagnos is and management of dementia, and has developed memory clinics in both urban and rural settings. She l eads the NHMRC Partnership Centre on Dealing with Cognitive and Related Functional Decline in Older People.
A/Professor Michael Woodward MB BS MD FRACP
Head of Aged Care Research and M emory Clinic , Austin Health, Heidelberg, VIC.
Associate Professor Michael Woodward is Head of Aged Care Research and the M emory Clinic at Austin Health in Melbourne, Victoria. He is a specialist in geriatric medicine with major interests in the treatment of Alzheimer’s disease (AD) and other dementias. He is Principal Investigator for numerous research trials of new therapies for AD and related disorders. He is immedi ate Past Presi dent of the AC4R – the Australasian Consortium of Centres for Clinical Cognitive Research that brings together researchers into therapeutic agents for dementia. He is also a member of the Alzheimer’s Australia Vic Board, being appointed their chief medical advisor and chair ing their research foundation, which administers over $2 million of research funding.
Michael Woodward’s publication record includes over 100 original research and review articles . H e has been awarded his MD on the overlap between the de mentia syndromes. More r ecent research interests have focussed on characterizing the frontal variant of Alzheimer’s Disease. He is a Fellow of the A ustralian A ssociation of G erontology (AAG) , the A ustralian and N ew Z ealand S ociety for G eriatric M edicine , t he A ustralian W ound M anagement A ssociation (AWMA) and the R oyal A ustralasian C ollege of P hysicians (RACP) and has long served each of these professional bodies , including becoming President of AWMA and AAG (Vic) and chairing the Committee for Physician Tra ining that oversaw the training of all RACP trainees
Clinical Associate Professor James Bur rell graduated from Arts/Medicine with Honours at UNSW in 2000. James received clinical training in medicine and neurology at Prince of Wales, Royal Prince Alfred, and Concord Hospitals in Sydney , becoming a Fellow of the Royal Australasian College of Physicians in 2008. James was awarded a scholarship from the MNDRIA and the NHMRC for a PhD with Professor s John Hodge s and Matthew Kiernan, which he completed in 2012. He was awarded an NHMRC Early Career Fellow ship (2013 – 2018) to study the overlaps between frontotemporal dementia and motor neuron disease, as wel l as young – onset and atypical dementia syndromes . He maintains an ongoing interest in the uses of clinical research to improve patient care. James also r uns a Young – Onset Dementia c linic at Concord Hospital, where is employe d as Staff S pecialist in neurology.
Master Class 2020
ACUTE AND CHRONIC REHABILITATION FOR THE AGEING BRAIN
Rehabilitation after stroke is extensively researched and there is no doubt of its efficacy irrespective of age and extent of disability. In other conditions seen in the ageing brain such as dementia or Parkinson ’ s disease , rehabilitation is less commonly practiced particularly in the older age group despite strong evidence as to its benefits. Th is presentation will argue that much is known and the priority issues relate to gaps between the evidence and usual clinical practice.
Ian Cameron is a Rehabilitation Physician at Hornsby Ku – ring – gai Hospital in northern Sydney and at Batemans Bay and Moruya Hospital s in southern NSW. H e is Head of the John Walsh Centre for Rehabilitation Research and has a Chair in Rehabilitation Medicine in the Faculty of Medicine and Health at the University of Sydney . H e has had a long interest in rehabilitation and older people with hip fracture, stroke and cognitive impairment. He is working with national and international societies to encourage research and education about rehabilitation and older people.
Dementia with Lewy bodies – diagnosis and management
Dementia with Lewy bodies (DLB) is the second most common neurodegenerative disease in the elderly. It is associated with significantly higher morbidity, socioeconomic burden, and carer distress relative to Alzheimer’s disease. Yet despite its prognostic and therapeutic relevance, DLB remains relatively under – diagnosed in the community. To improve its diagnosis, the diagnostic criteria for DLB recently underwent major revision w ith the inclusion of REM sleep behavior disorder as a core feature of the disease. In this lecture, the most up to date diagnostic criteria are reviewed, focusing on strategies for clinically differentiating DLB from other forms of dementia. This will be f ollowed by an overview of the latest non – pharmacological and pharmacological therapies for DLB.
Dr Elie Matar MD BSc (Adv)
Dr Elie Matar is a clinical lecturer and NHMRC postgraduate PhD scholar working with Professor Simon Lewis and Professor Glen da Halliday at the Brain and Mind Centre in Sydney. His research interests include the phenomenology, pathophysiology and progression of synuclein – based disorders. His current work involves investigating neuroimaging, sleep – EEG and clinical correlates of s ymptoms including cognitive impairment, fluctuations and visual hallucinations across the spectrum of Lewy body disease. He has authored notable publications in the field and presents his work regularly at international meetings. In 2018 he was awarded the Young Investigator award by the International Movement Disorders Society. He is the recipient of the Australian and New Zealand Association of Neurologists Gwen James dementia Fellowship and the Jim Lance Award. In 2019 he was a visiting clinician at the Mayo Clinic, Rochester (US) and undertook an Endeavour Leadership fellowship based at the University of Cambridge. He has given several invited lectures including most recently at the University of Newcastle, and the National Hospital of Neurology and Neur osurgery in London. Elie is currently undertaking his core training at Westmead Hospital, Sydney.
Dr Hassan graduated in 2000 with Honours from the University of NSW. He completed his basic physician training at Westmead Hopsital. He completed his advanced neurology training through Westmead and Nepean Hospitals before completing further research and a neurophysiology fellowship at Royal Prince Alfred Hospital. He worked as a staff specialist at Westmead and Blacktown Hospitals for several years then gradually drifted into full time private practise. His areas of special interests include nerve conduction studies/electromyography and headache management including Botulinum toxin injections. He currently practices at Campsie and Liverpool and is a visiting medical officer at Liverpool hospital.
Dr Alessandro (Alex) Fois is a neurologist in practice at the Woolcock Institute and Harbour Neurology Group (North Sydney). He received his medical degree from Oxford University and completed his postgraduate training in Cambridge, UK and Sydney, Australia. He is a Clinical Lecturer with the University of Sydney and a Research Fellow within the Westmead Hospital Movement Disor
ders Unit and is completing a PhD supported by the Brain Foundation and an NHMRC Postgraduate Scholarship. Alex’s research is focussed on tremor and he has authored several publications and book chapters on the subject of tremor and movement disorders. In additional to his clinical and research work in Sydney, Alex is passionate about telehealth and extending the reach of neurological care to regional Australia, and he provides a visiting outpatient neurology service to St Stephen’s Hospital in Hervey Bay, Queensland.
Although we have done comparatively well in Australia, the COVID pandemic has brought the words death & dying to the fore, especially with regards to older people. Overseas, COVID is almost synonymous with ageing and death. Perhaps we can use the luxury of living and working in Australia to inspire change. This presentation will explore the opportunities for us as clinicians to improve the care and advocate for the human rights of people with diseases of the ageing brain at the end of life. We can do better.